ProSense® — NDA/BLA submission
in June 2027
The decision by the American Medical Association's CPT Editorial Panel provides additional time for the Company to continue expanding clinical evidence, increasing utilization of the Company's ProSense system, and working closely with leading medical societies toward a potential resubmission of the CPT category I code request in June 2027.Source filing